Skip to: Content
Skip to: Site Navigation
Skip to: Search

July 25, 2008 7:55:50 AM CDT

Learn about Newser Points »

Stories related to: Vioxx

Stories

7 Stories

  • May 2008

    • Court Tosses $32M Verdict Against Vioxx

      newser  |  Wall Street Journal  |  May 14, 08 1:29 PM CDT

      Court Tosses $32M Verdict Against Vioxx

      A Texas appellate court threw out a $32 million verdict against Merck today, citing a lack of evidence that Vioxx contributed to a man’s fatal heart attack. Lionel Garza was taking the painkiller when he died in 2001 at age 71, but was also a smoker with high blood pressure and high cholesterol, the Wall Street Journal reports. The Garza case was decided by verdict in 2006, and was excluded from a recent $4.85 billion settlement for 27,000 Vioxx cases. More »

      Tags

      lawsuit  • painkiller  • pharmaceutical industry  • Vioxx  • Merck and Co.

  • April 2008

    • Merck Used Ghostwriters to Draft Rosy Vioxx Studies

      newser  |  Wall Street Journal  |  Apr 15, 08 7:51 PM CDT

      Merck Used Ghostwriters to Draft Rosy Vioxx Studies

      Merck used its own ghostwriters to draft articles minimizing risks of its drug Vioxx, then found medical researchers to lend their names to the research, the Wall Street Journal reports. Merck, which pulled the painkiller from shelves four years ago over heart-attack risks, rejects the claims as "misleading." They appear in tomorrow's edition of the Journal of the American Medical Association . More »

      Tags

      ethics  • pharmaceutical companies  • Merck  • Vioxx  • medical studies  • JAMA

  • February 2008

    • Merck Will Pay $650M to End Discount Probes

      newser  |  Wall Street Journal  |  Feb 7, 08 3:59 PM CST

      Merck Will Pay $650M to End Discount Probes

      Drug company Merck will dish out $650 million to resolve lawsuits and probes into marketing schemes, the Wall Street Journal reports. Central to the investigations is the company’s “nominal pricing,” which slashed some drug prices by 90% for hospitals but hid the discounts from Medicaid, even though federal law demands that drug companies offer the government program their lowest prices. More »

      Tags

      lawsuit  • drugs  • pharmaceutical companies  • hospitals  • Merck  • Vioxx  • probe  • Zocor

  • December 2007

    • Merck Recalls 1M Doses of Vaccine for Kids

      newser  |  Associated Press  |  Dec 12, 07 7:14 PM CST

      Merck Recalls 1M Doses of Vaccine for Kids

      Merck is recalling almost a million doses of a childhood vaccine after it found evidence of contamination at one of its factories, the AP reports. The pharmaceutical giant says no children have been harmed after taking Hib, which prevents meningitis and pneumonia, but the company is recalling its 10 lots and two lots of a combination vaccine for both Hib and hepatitis B. More »

      Tags

      Merck  • vaccine  • pharmaceutical industry  • Vioxx  • pneumonia  • meningitis  • hepatitis B

  • November 2007

    • Merck to Settle Suits for $4.85B

      newser  |  New York Times  |  Nov 9, 07 5:19 AM CST

      Merck to Settle Suits for $4.85B

      Merck has agreed to shell out $4.85 billion to settle 27,000 Vioxx lawsuits brought by plaintiffs who argued that the pain medication damaged health and caused deaths. The agreement, one of the largest in history, must still be approved by 85% of the plaintiffs, but it's likely to go through, reports the New York Times. More »

      Tags

      settlement  • civil lawsuits  • Merck  • painkiller  • Vioxx  • drug safety

  • May 2007

    • Drug Company Nemesis Strikes Again

      newser  |  Wall Street Journal  |  May 22, 07 1:32 PM CDT

      Drug Company Nemesis Strikes Again

      The doctor who helped to raise concerns about the painkiller Vioxx is back—with the study released earlier this week linking the same company's popular diabetes drug, Avandia, to higher risk of heart attacks. The Wall Street Journal looks at 58-year-old cardiologist Steven Nissen's role in identifying and publicizing drug risks. More »

      Tags

      drugs  • medicine  • FDA  • diabetes  • pharmaceutical companies  • GlaxoSmithKline  • Avandia  • Vioxx

    • FDA Given New Muscle To Monitor Drugs

      newser  |  New York Times  |  May 10, 07 5:41 AM CDT

      FDA Given New Muscle To Monitor Drugs

      The Food and Drug Administration would be given sweeping new powers to order drug recalls, regulate advertising and mandate changes in labels under a bill passed by the Senate yesterday. The bill signals a fundamental shift in the FDA's role, the New York Times reports, requiring the agency to track drugs after, as well as before, approval. More »

      Tags

      drugs  • FDA  • safety  • recall  • drug companies  • Vioxx

7 Stories

Today's Most Popular

Loading...

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »